Victorian government funding boost for new anti-inflammatory treatments
Hudson Institute’s groundbreaking research into new anti-inflammatory treatments has attracted the support of the Victorian government, in recognition of its potential to treat COVID-19 and other infectious diseases.… Read more
RNA boost for autoimmune disease
The enormous potential of RNA-based treatments for autoimmune diseases has been recognised by the Victorian government, with a new grant from the mRNA Victoria Research Acceleration Fund.… Read more
Flicking the inflammation off-switch
Many human diseases, including autoimmune diseases such as arthritis or inflammatory bowel disease, are characterised by too much inflammation.
There has been a gap in producing new generations of potent anti-inflammatory therapeutics for these anti-inflammatory conditions.… Read more
Silicosis research awarded more than $1.6 million
Hudson Institute of Medical Research and Monash University have received more than $1.6 million in funding from the Federal Government’s Medical Research Future Fund (MRFF) towards research investigating ways to prevent and treat silicosis.… Read more
Ovarian cancer treatment hope
Hudson Institute researchers have shown for the first time that a diabetes drug called sitagliptin can limit tumour growth, and possibly extend survival rates from epithelial ovarian cancer, the most common and dangerous type of ovarian cancer.… Read more
NHMRC Ideas Grants success
Hudson Institute has been successful in the NHMRC Ideas Grant round. Our researchers have been awarded four NHMRC Ideas Grants, totalling almost $4.1 million.… Read more
World-leading National Centre for Inflammation Research to be established in Victoria following budget boost
Hudson Institute of Medical Research today welcomed the Victorian Government’s initial investment to kick-start a National Centre for Inflammation Research (NCIR) to be established at the Monash Health Translation Precinct (MHTP) in Melbourne’s growing south-eastern corridor.… Read more
ARC Discovery Projects success
Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.… Read more
Motor neuron disease inflammation trigger discovered
In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,… Read more
US President Donald Trump has COVID-19 and is on a cocktail of experimental drugs. What does this mean for his health?
It is unknown how US President Donald Trump will respond to the experimental immunotherapy given to treat his COVID-19 infection, because the drug has not yet been tested and approved, says Hudson Institute Director and CEO, Professor Elizabeth Hartland.… Read more
Skip to content
